SCHEMBL108996

SCHEMBL108996

CCC(C)C(O)CC(C)C

nearest known ligand 0.42

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
TSHR P16473 4/20 0.42
TRPA1 O75762 1/20 0.32
ALDH1A1 P00352 1/20 0.32
MAPK1 P28482 1/20 0.32
ANPEP P15144 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19767656 0.95 TSHR (0.38) TSHRTRPA1
SCHEMBL108644 0.83 TSHR (0.38) TSHRTRPA1
SCHEMBL5907214 0.82 TSHR (0.50) TSHRTRPA1ALDH1A1
SCHEMBL28946275 0.80 TSHR (0.40) TSHRTRPA1
SCHEMBL16882890 0.80 TSHR (0.40) TSHRTRPA1
SCHEMBL108859 0.80 TSHR (0.40) TSHRTRPA1
SCHEMBL4634456 0.80 TSHR (0.40) TSHRTRPA1
SCHEMBL12042669 0.79 TSHR (0.44) TSHRTRPA1ALDH1A1MAPK1ANPEP
SCHEMBL12042667 0.79 TSHR (0.44) TSHRTRPA1ALDH1A1MAPK1ANPEP
SCHEMBL7325421 0.79 TSHR (0.44) TSHRTRPA1ALDH1A1MAPK1ANPEP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 136 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3029075-B1 DEVICE AND METHOD FOR RE-CIRCULATING RAW MATERIAL USED WHEN MANUFACTURING POLYBUTENE DL CHEMICAL CO LTD (KR) 2023-09-20 EP claimed
EP-3730522-B1 METHOD FOR PRODUCING HIGHLY REACTIVE POLYBUTENE DL CHEMICAL CO LTD (KR) 2023-03-08 EP claimed
EP-3205674-B1 APPARATUS AND METHOD FOR PREPARING POLYBUTENE HAVING VARIOUS MOLECULAR WEIGHTS DL CHEMICAL CO LTD (KR) 2022-08-03 EP claimed
EP-3006469-B1 APPARATUS AND METHOD FOR PREPARING POLYBUTENE HAVING VARIOUS MOLECULAR WEIGHTS DAELIM IND CO LTD (KR) 2019-08-21 EP claimed
EP-2463374-A2 Isolated alcohol dehydrogenase enzymes and uses thereof Bio Architecture Lab, Inc. (US) 2012-06-13 EP claimed
EP-2195440-A2 BIOFUEL PRODUCTION Bio Architecture Lab, Inc. (US) 2010-06-16 EP claimed
US-20090155873-A1 BIOFUEL PRODUCTION BIO ARCHITECTURE LAB, INC. (US) 2009-06-18 US claimed
US-20090139134-A1 BIOFUEL PRODUCTION BIO ARCHITECTURE LAB, INC. (US) 2009-06-04 US claimed
WO-2009046375-A2 BIOFUEL PRODUCTION BIO ARCHITECTURE LAB, INC. (US) 2009-04-09 WO claimed
WO-2009046370-A2 BIOFUEL PRODUCTION BIO ARCHITECTURE LAB, INC. (US) 2009-04-09 WO claimed
EP-3230463-B2 RAPID PRETREATMENT APALTA PATENTS OUE (EE) 2025-07-16 EP disclosed
US-20240425893-A1 RAPID PRETREATMENT Apalta Patents OÜ (EE) 2024-12-26 US disclosed
US-12054761-B2 Rapid pretreatment Apalta Patents OÜ (EE) 2024-08-06 US disclosed
US-11821047-B2 High pressure zone formation for pretreatment Apalta Patent OÜ (EE) 2023-11-21 US disclosed
US-20230295678-A1 RAPID PRETREATMENT Apalta Patents OÜ (EE) 2023-09-21 US disclosed
WO-2009097346-A2 ISOLATED ALCOHOL DEHYDROGENASE ENZYMES AND USES THEREOF BIO ARCHITECTURE LAB, INC. (US) 2009-08-06 WO disclosed
US-20090155873-A1 BIOFUEL PRODUCTION BIO ARCHITECTURE LAB, INC. (US) 2009-06-18 US disclosed
US-20090139134-A1 BIOFUEL PRODUCTION BIO ARCHITECTURE LAB, INC. (US) 2009-06-04 US disclosed
WO-2009046375-A2 BIOFUEL PRODUCTION BIO ARCHITECTURE LAB, INC. (US) 2009-04-09 WO disclosed
WO-2009046370-A2 BIOFUEL PRODUCTION BIO ARCHITECTURE LAB, INC. (US) 2009-04-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090139134-A1 BIOFUEL PRODUCTION MGAM, DCXR, MANBA TSHR 3426/4885TRPA1 3765/4885ALDH1A1 753/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.